Atlas Trials

A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

Clinical trial NCT05259722 · COMPLETED

Trial details

NCT number
NCT05259722
Sponsor
LEO Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Hand Eczema
Start date
2022-06-15
Primary completion
2023-11-08
Enrollment
513

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.